MFSD2A potentiates gastric cancer response to anti‐PD‐1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response

Bin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xuetao Cao(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cancer Communications
August 4, 2023
10.1002/cac2.12476
Cited by 40

Related Papers

Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation
|Nature Communications|2019|517
Interleukin-17 and its expanding biological functions
|Cellular and Molecular Immunology|2010|369
MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma
|Journal of Biological Chemistry|2011|248
Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity
|Nature Immunology|2016|200
Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27
|Cell Research|2015|191